Year in Review 2024 - NSCLC Perioperative Therapy

Oncology 2024 Year in Review

B. Halmos

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

Total Health

D. Carbone

The Non-Invasive Diagnosis of Lung Cancer

Memorial Sloan Kettering Cancer Center

G. Rocco

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Nodules and Lung Cancer Screening

Fox Chase Cancer Center

R. Kumar

Role of Surgery in Locally Advanced NSCLC

Memorial Sloan Kettering Cancer Center

K. Gray

ESMO 2024 Summary: Key Trial Insights on Managing NSCLC With Low PD-…

ecancer

L. Paz-Ares

Adjuvant & Neoadjuvant Therapy in Early NSCLC With Actionable Genomi…

Fox Chase Cancer Center

J. Reuss

Thoracic Malignancies From an Interventional Pulmonologist's Perspec…

Fox Chase Cancer Center

C. Manley

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

IO Advances in Metastatic NSCLC Treatment

Fox Chase Cancer Center

H. Borghaei

Imaging of Precision Therapy in Lung Cancer

International Cancer Imaging Society (ICIS)

M. Nishino

An Update of ADC Toxicities in Solid Tumors

OncoAlert

M. Lustberg

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Current Landscape of Neoadjuvant, Perioperative, and Adjuvant IO in …

UCLA Health

J. Lee

Unresectable Stage 3 NSCLC: Patient Selection and Treatment Options

Fox Chase Cancer Center

C. Aggarwal

Year in Review 2024 - Targeted Therapy for NSCLC

Nebraska Oncology Society

J. Murray

Lung Cancer Screening Guidelines and Care

Yale Cancer Center

E. Winer, L. T Tanoue

The Efficacy of Immunotherapies for EGFRm Lung Cancer

GRACE

I. Dagogo-Jack, J. Rotow, M. Shields, A. Cooper, A. Qin

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles